Curated coverage for pharma with top developments, timeline context, and connected threads.
Gut bacteria can metabolise and inactivate your medications before they reach the bloodstream. New research shows this varies enormously between people and explains why drugs work differently for different people.
EuroBulletin24 Editorial Desk | Linked source
Cell-free protein production platforms can make vaccines and drugs without living organisms. Here is what this breakthrough means for vaccine manufacturing speed and cost.
The US-EU trade framework was negotiated to provide stability. Here is why, less than a year in, it is already being stress-tested by the IEEPA ruling, NATO threats, and pharmaceutical tariff signals.
Europe gets 70-80% of its generic medicine from India. The US pharmaceutical tariff threat and India's own policy changes are creating supply chain risks that European health ministries are quietly worried about.
A 200% pharmaceutical tariff would be economically catastrophic for American patients. Here is exactly why the supply chain cannot be reshored quickly enough to prevent it.
The Trump administration has signaled pharmaceutical tariffs could reach 200% by mid-to-late 2026. Here is what would happen to the price of medicines for American patients and globally.
AI systems are now designing entirely new drug molecules that chemists have never imagined. Here is the state of AI-powered drug discovery and what it means for medicine.